(Q38354884)

English

Receptor Tyrosine Kinases Inhibit Bone Morphogenetic Protein‐Smad Responsive Promoter Activity and Differentiation of Murine MC3T3‐E1 Osteoblast‐like Cells

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Receptor Tyrosine Kinases Inhibit Bone Morphogenetic Protein‐Smad Responsive Promoter Activity and Differentiation of Murine MC3T3‐E1 Osteoblast‐like Cells (English)

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

0 references

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733721

30 December 2023

Orthopedics and sports medicine

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

5

object named as

Seiji Fukumoto

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733721

30 December 2023

6

object named as

Mitsuyasu Kato

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733721

30 December 2023

author name string

Konosuke Nakayama

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Yasuhiro Tamura

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Miyuki Suzawa

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Shun-Ichi Harada

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Kohei Miyazono

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Yasuhiro Takeuchi

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Toshiro Fujita

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Gideon A. Rodan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733721

30 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12733721

30 December 2023

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1359%2Fjbmr.2003.18.5.827

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

https://onlinelibrary.wiley.com/doi/full/10.1359/jbmr.2003.18.5.827

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

827-835

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Skeletal growth factors

1

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Bone growth factors

3

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Bone: formation by autoinduction

4

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography

5

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Novel regulators of bone formation: molecular clones and activities

6

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone

7

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2

8

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro

9

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage

10

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells

11

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing

14

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing

15

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Expression of BMP-2 and TGF-beta 1 mRNA during healing of the rabbit mandible

16

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation

17

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats

18

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats

19

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Effects of acidic and basic fibroblast growth factors on osteoblastic cells

21

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells

23

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Osteoblasts are target cells for transformation in c-fos transgenic mice

24

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

FGF-4 and BMP-2 have opposite effects on limb growth.

25

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Effect of protein and steroidal osteotropic agents on differentiation and epidermal growth factor-mediated growth of the CFK1 osseous cell line

27

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2.

30

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells

31

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

SMADs: mediators and regulators of TGF-beta signaling

32

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

TGF-beta signal transduction

33

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins

34

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

TGF-beta signaling by Smad proteins

35

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Induction of Smad6 mRNA by bone morphogenetic proteins

36

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter

37

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts

38

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Establishment of a clonal osteogenic cell line from newborn mouse calvaria

39

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Lipofection reagents prepared by a simple ethanol injection technique

40

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

A human Mad protein acting as a BMP-regulated transcriptional activator

41

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells

42

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1

43

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes

44

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Differentiation and cell surface expression of transforming growth factor-beta receptors are regulated by interaction with matrix collagen in murine osteoblastic cells

45

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells

46

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation

47

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

48

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

49

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

50

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor

51

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1.

52

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells

53

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity

54

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

55

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300

56

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation

57

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells

58

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Physical and functional interaction of SMADs and p300/CBP

59

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation

60

1 reference

10.1359/JBMR.2003.18.5.827

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.827

30 December 2023

Identifiers

10.1359/JBMR.2003.18.5.827

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38354884&oldid=2040992956"